CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies for cancer, today announced that members of the management team will present at the Goldman Sachs 37th Annual Healthcare Conference on June 8, 2016 at 8:00 am PT (11:00 am ET). The conference is being held June 7-9, 2016 at the Terranea Resort in Rancho Palos Verdes, Calif.
